首页|110例地塞米松治疗癌症相关性乏力的疗效安全性观察

110例地塞米松治疗癌症相关性乏力的疗效安全性观察

扫码查看
目的:观察地塞米松对癌症相关性乏力的疗效和安全性。方法对110位伴有乏力症状的晚期肿瘤患者,给予地塞米松片剂治疗,运用简明乏力量表,通过对患者治疗前后的乏力评分,分析癌症相关性乏力缓解疗效;以及影响其疗效相关因素。结果地塞米松片剂能有效缓解晚期肿瘤患者癌性相关性乏力且与年龄和性别无相关性。结论地塞米松对癌症相关性乏力治疗有效。
objective observation of therapeutic effects of dexamethasone on cancer-related fatigue and safety.Method to 110 with fatigue symptoms in patients with advanced tumors, giving dexamethasone treatment, use of a simplified table spent force, through the patients before and after treatment of anemic ratings, analysis of therapeutic effects of cancer-related fatigue mitigation and related factors influencing outcomes.Results dexamethasone tablets can effectively al eviate the cancer correlation between fatigue in patients with advanced cancer and no correlation with age and gender. Conclusion dexamethasone for treatment of cancer-related fatigue is valid.

DexamethasoneCancer-relatedfatigue

沈超、施丽霞、陈柳、孙瑛、沈伟

展开 >

上海交通大学医学院附属新华医院崇明分院宁养院 202150

地塞米松 癌症相关性乏力

2014

中外健康文摘
中国中医药报社

中外健康文摘

影响因子:0.016
ISSN:1672-5085
年,卷(期):2014.(1)
  • 1
  • 1